tradingkey.logo
tradingkey.logo
검색

Merck & Co Inc

MRK
관심 목록에 추가
120.360USD
+0.760+0.64%
시장 운영 시간 ET시세는 15분 지연됩니다
299.38B시가총액
33.74P/E TTM

자세한 내용은 Merck & Co Inc 회사

Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.

Merck & Co Inc 정보

종목 코드 MRK
회사 이름Merck & Co Inc
상장일Feb 06, 2077
CEODavis (Robert M)
직원 수75000
유형Ordinary Share
회계 연도 종료Feb 06
주소126 East Lincoln Avenue
도시RAHWAY
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가United States of America
우편 번호07065
전화19087404000
웹사이트https://www.merck.com/
종목 코드 MRK
상장일Feb 06, 2077
CEODavis (Robert M)

Merck & Co Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Robert M. (Rob) Davis
Mr. Robert M. (Rob) Davis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
450.35K
+1.50%
Mr. Sanat Chattopadhyay
Mr. Sanat Chattopadhyay
Executive Vice President and President - Merck Manufacturing Division
Executive Vice President and President - Merck Manufacturing Division
200.68K
+0.73%
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Executive Vice President, President - Merck Research Laboratories
Executive Vice President, President - Merck Research Laboratories
94.43K
+2.54%
Ms. Jennifer L. Zachary
Ms. Jennifer L. Zachary
Executive Vice President, General Counsel
Executive Vice President, General Counsel
70.41K
+2.13%
Mr. Chirfi Guindo
Mr. Chirfi Guindo
Senior Vice President, Chief Marketing Officer - Human Health
Senior Vice President, Chief Marketing Officer - Human Health
56.20K
+1.78%
Mr. Joseph Edward Romanelli
Mr. Joseph Edward Romanelli
Senior Vice President, President - MSD International Human Health
Senior Vice President, President - MSD International Human Health
28.61K
+19.93%
Ms. Patricia F. Russo
Ms. Patricia F. Russo
Independent Director
Independent Director
13.15K
--
Mr. Thomas Henry (Tom) Glocer, J.D.
Mr. Thomas Henry (Tom) Glocer, J.D.
Lead Independent Director
Lead Independent Director
5.10K
--
Mr. Inge G. Thulin
Mr. Inge G. Thulin
Independent Director
Independent Director
2.93K
--
Ms. Pamela J. Craig
Ms. Pamela J. Craig
Independent Director
Independent Director
1.72K
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Robert M. (Rob) Davis
Mr. Robert M. (Rob) Davis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
450.35K
+1.50%
Mr. Sanat Chattopadhyay
Mr. Sanat Chattopadhyay
Executive Vice President and President - Merck Manufacturing Division
Executive Vice President and President - Merck Manufacturing Division
200.68K
+0.73%
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Executive Vice President, President - Merck Research Laboratories
Executive Vice President, President - Merck Research Laboratories
94.43K
+2.54%
Ms. Jennifer L. Zachary
Ms. Jennifer L. Zachary
Executive Vice President, General Counsel
Executive Vice President, General Counsel
70.41K
+2.13%
Mr. Chirfi Guindo
Mr. Chirfi Guindo
Senior Vice President, Chief Marketing Officer - Human Health
Senior Vice President, Chief Marketing Officer - Human Health
56.20K
+1.78%
Mr. Joseph Edward Romanelli
Mr. Joseph Edward Romanelli
Senior Vice President, President - MSD International Human Health
Senior Vice President, President - MSD International Human Health
28.61K
+19.93%

자주 묻는 질문

Merck & Co Inc의 상위 5대 주주는 누구인가요?

Merck & Co Inc의 상위 5대 주주는 다음과 같습니다: Mr. Robert M. (Rob) Davis

Merck & Co Inc(MRK)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Merck & Co Inc의 주식을 보유한 기관은 총 5687곳이며, 이들이 보유한 주식의 총 가치는 약 2.01B로 전체 발행 주식의 81.41%를 차지합니다. 이는 2025Q4 대비 -10595247.00 증가한 수치입니다.

Merck & Co Inc의 최대 수익원은 무엇인가요?

2026Q1 기준, Merck & Co Inc의 Oncology-Keytruda 부문이 가장 높은 매출을 기록했으며, 금액은 31.64B로 전체 매출의 48.67%를 차지했습니다.
KeyAI